Friday, June 14, 2024 6:01:50 PM
They have a license for TIL plus a neoantigen vaccine https://www.federalregister.gov/documents/2024/02/07/2024-02491/prospective-grant-of-an-exclusive-patent-license-vaccine-augmented-adoptive-cell-therapy-for-the
Preclinical data on the vaccine https://jitc.bmj.com/content/11/Suppl_1/A418
Recent LYEL News
- Form 8-K - Current report • Edgar (US Regulatory) • 11/07/2024 09:09:36 PM
- Lyell Immunopharma Reports Business Highlights and Financial Results for the Third Quarter 2024 • GlobeNewswire Inc. • 11/07/2024 09:05:00 PM
- Lyell Announces Presentation of Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the treatment of B-cell Lymphoma at the 2024 American Society of Hematology (ASH) Annual Meeting • GlobeNewswire Inc. • 11/05/2024 02:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:45:59 PM
- Lyell Immunopharma Completes Acquisition of ImmPACT Bio • GlobeNewswire Inc. • 10/31/2024 08:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2024 08:06:00 PM
- Lyell Immunopharma to Acquire ImmPACT Bio and Prioritizes its Pipeline to Focus on Next-Generation CAR T-cell Therapies • GlobeNewswire Inc. • 10/24/2024 08:00:00 PM
- Lyell Immunopharma Announces the Acceptance Abstracts for Presentation at 2024 Society for Immunotherapy of Cancer (SITC) Annual Meeting • GlobeNewswire Inc. • 10/04/2024 01:00:00 PM
- Lyell Immunopharma Announces Participation in Goldman Sachs Cell Therapy Day • GlobeNewswire Inc. • 09/24/2024 08:05:00 PM
- Lyell Immunopharma Announces Participation in September Investor Conferences • GlobeNewswire Inc. • 08/28/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:06:44 PM
- Lyell Immunopharma Reports Business Highlights and Financial Results for the Second Quarter 2024 • GlobeNewswire Inc. • 08/07/2024 08:05:00 PM
- Lyell Immunopharma Reports Dose-dependent Clinical Activity from Phase 1 Trial of LYL797, a ROR1-targeted CAR-T Cell Product Candidate Enhanced with its Proprietary Anti-exhaustion Technology • GlobeNewswire Inc. • 06/26/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 08:07:01 PM
- Lyell Immunopharma to Participate in the Goldman Sachs Global Healthcare Conference • GlobeNewswire Inc. • 06/03/2024 08:05:00 PM
- Lyell Immunopharma to Participate in BofA Securities Health Care Conference • GlobeNewswire Inc. • 05/07/2024 08:05:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 05/06/2024 12:12:11 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 12:06:23 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 12:03:04 PM
- Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2024 • GlobeNewswire Inc. • 05/06/2024 12:00:00 PM
- Lyell Immunopharma Announces the Acceptance of Three Abstracts for Presentation at 2024 AACR Annual Meeting • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:07:21 PM
- Lyell Immunopharma Reports Business Highlights and Financial Results for the Fourth Quarter and Full Year 2023 • GlobeNewswire Inc. • 02/28/2024 09:05:00 PM
- Lyell Immunopharma Announces Participation in March Investor Conferences • GlobeNewswire Inc. • 02/26/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 01:24:01 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM